Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Piebaldism”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Post-approval studies (Phase 4)UnknownNCT01377077
What this trial is testing

Punchgrafting Techniques for Vitiligo

Who this might be right for
Non-segmental VitiligoSegmental VitiligoPiebaldism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35
Large-scale testing (Phase 3)Not Yet RecruitingNCT05970900
What this trial is testing

Preoperative Imatinib Mesylate Combined With Rectal-sparing Surgery in Patients With c-KIT Gene-mutant Rectal GIST

Who this might be right for
Gastrointestinal Stromal Tumor of Rectum
Fujian Medical University Union Hospital 23
Early research (Phase 1)UnknownNCT03351400
What this trial is testing

Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration

Who this might be right for
Chronic Heart FailureOld Myocardial Infarction
Sakakibara Heart Institute 6
Not applicableStudy completedNCT00336076
What this trial is testing

Molecular Mechanisms and Diagnosis of Mastocytosis

Who this might be right for
Mastocytosis
University of Michigan 136
Testing effectiveness (Phase 2)Study completedNCT01126814
What this trial is testing

Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

Who this might be right for
Leukemia
University Health Network, Toronto 35
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Large-scale testing (Phase 3)Study completedNCT02156427
What this trial is testing

Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

Who this might be right for
VitiligoPiebaldism
Laboratoires Genévrier 38
Large-scale testing (Phase 3)Study completedNCT00814073
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 135
Testing effectiveness (Phase 2)Study completedNCT02272998
What this trial is testing

Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

Who this might be right for
Malignant Neoplasm
Sameek Roychowdhury 22
Large-scale testing (Phase 3)UnknownNCT04333108
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 140
Post-approval studies (Phase 4)UnknownNCT01640678
What this trial is testing

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Who this might be right for
PiebaldismSegmental Vitiligo
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 10
Not applicableStudy completedNCT05544578
What this trial is testing

Korean Translation and Validation of the K-HEPI in NYC

Who this might be right for
DisasterVulnerable Populations
Hunter College of City University of New York 400
Not applicableStudy completedNCT05455580
What this trial is testing

Nurses Taking On Readiness Measures - Mercer County, New Jersey

Who this might be right for
DisasterVulnerable Populations
Hunter College of City University of New York 31
Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Not applicableLooking for participantsNCT05584488
What this trial is testing

Allergy and Immunology Natural History Study

Who this might be right for
Immune DeficiencyImmune Dysregulation DisorderAllergic Inflammation
Columbia University 10,000
Post-approval studies (Phase 4)Study completedNCT02458417
What this trial is testing

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Who this might be right for
Segmental VitiligoPiebaldism
Netherlands Institute for Pigment Disorders 10